Novel Tools for Accelerated Biopharmaceutical Development
Lead Participant:
GLAXOSMITHKLINE PLC
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Lead Participant | Project Cost | Grant Offer |
|---|---|---|
| GLAXOSMITHKLINE PLC | £369,657 | £ 103,504 |
Participant |
||
| UCB CELLTECH | £202,024 | £ 60,607 |
| UNIVERSITY OF NOTTINGHAM | £241,978 | £ 241,978 |
| THE HEALTH PROTECTION AGENCY (HPA NIBSC) | £9,496 | £ 4,748 |
| LGC LIMITED | £571,255 | £ 285,628 |
| NPL MANAGEMENT LIMITED | £253,451 | £ 126,726 |
People |
ORCID iD |